Response: Commentary: An In Silico–In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients

Response: Commentary: An In Silico–In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients

Bibliographic Details
Main Authors: Michele Mishto, Guillermo Rodriguez-Hernandez, Jacques Neefjes, Henning Urlaub, Juliane Liepe
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Immunology
Subjects:
proteasome
peptide splicing
antigen presentation
tumor immunology
mass spectrometry
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.679836/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.679836/full

Similar Items